There is some anecdotal evidence that commercial pressures cause scientists to withhold data or suppress publication of study results. Some delay in publication may be warranted in order to allow for patenting of intellectual property. However, as federal funding for research declines and the cost of engaging in research continues to rise, many investigators and institutions have increasingly turned towards corporate sources to fund their research agendas, often signing confidentiality agreements in the process. The question immediately arises: To what extent should commercial forces shape the pursuit of academic truth? Can a balance be struck between commercial interests on the one hand and academic freedom on the other?
Hrachovec JB, Mora M, Wright JM, Perry TL, Bassett KL, Chambers GK. Reporting of 6-Month vs 12-Month Data in a Clinical Trial of Celecoxib (correspondence). JAMA 2001(Nov 21);286(19):2398-2400. [See also original article: Silverstein FE, Faich G, Goldstein JL, et al, for the Celecoxib Long-Term Arthritis Safety Study. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 2000(Sep 13);284:1247-1255.]
Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke JP, Sox HC, Van Der Weyden MB, Wilkes MS. Sponsorship, Authorship, and Accountability. CMAJ 2001;165(6):786-8. Also in: Ann Int Med 2001(Sep 18);135(6):463-466 -- JAMA 2001(Sep 12);286(10:1232-34 -- MJA 2001; 175: 294-296 -- and The Lancet 2001(Sep 15);358(9285):854-56.
Bodenheimer T. Uneasy Alliance -- Clinical Investigators and the Pharmaceutical Industry. NEJM 2000(May 18);342(20):1539-44. [See also replies in NEJM 2000(Aug 17);343(7):510-11.]
Angell M. Is Academic Medicine for Sale? NEJM 2000(May 18);342(20):1516-18. [See also replies in NEJM 2000(Aug 17);343(7):508-10.]
Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. NEJM 1998;338:101-106. [See also replies in NEJM 1998(Jun 4);338:1696-1698.]
Deyo RA, Psaty BM, Simon G, Wagner EH, Omenn GS. The Messenger under Attack -- Intimidation of Researchers by Special-Interest Groups.NEJM 1997(Apr 17);336(16):1176-80. [See also replies in NEJM 1997(Oct 30);337(18):1314-19.]
Rennie D. Thyroid storm. JAMA. 1997 Apr 16;277(15):1238-43.
Angell M, Kassirer JP. Editorials and Conflicts of Interest. NEJM 1996(Oct 3);335(14):1055-56. [See also replies in NEJM 1997(Mar 6);336(10):728-29.]
